New Venture Funds Target Canadian Innovation
It is often said that start-up and emerging biotechnology companies require patient capital in order to execute on their business plans. Unfortunately, for Canadian biotechs they have had to be extremely patient waiting for capital.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST